For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Androstenedione: 4-Androstenedione (androst-4-ene-3,17-dione) - an endogenous weak androgen and estrogen and intermediate to/prohormone of testosterone.
Scope of the Report:
This report focuses on the Androstenedione in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Androstenedione is used to evaluate the function of the adrenal gland and the ovaries or the testicles as well as the production of hormones related to the development of male sex organs and physical characteristics (androgens). It is most commonly used to determine the cause of symptoms of excess androgens in a woman who has an elevated testosterone level, along with a few other laboratory tests for this purpose.
Androstadienedione (1,4-androstadiene-3,17-dione) is an important industrial precursor for various steroid hormones. Androstadienedione is an important industrial-scale precursor for a wide variety of steroid hormones within the estrane and androstane classifications.
The worldwide market for Androstenedione is expected to grow at a CAGR of roughly 0.8% over the next five years, will reach 200 million US$ in 2023, from 190 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Indo Phyto Chemicals
- Sito Bio
- Goto Pharmaceutical
- Tianjin King York
- Yongning Pharma
- Jiangxi Hongyuan Pharmaceutical
- Xi'an Gaoyuan Bio-Chem
- Dongyao Pharmaceutical
- Huazhong Pharmaceutical
- Danjiangkou Danao
- Dahua Pharmaceutical
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Market Segment by Applications, can be divided into
- Arthritis Pharmaceuticals
- Fertility Control Pharmaceuticals
- Infectious Inflammation Pharmaceuticals
There are 15 Chapters to deeply display the global Androstenedione market.
Chapter 1, to describe Androstenedione Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Androstenedione, with sales, revenue, and price of Androstenedione, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Androstenedione, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Androstenedione market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Androstenedione sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source